Related Experiment Videos

Stability of amphotericin B in CAPD fluid

R Janknegt1, A Paulissen, P M Hooymans

  • 1Department of Clinical Pharmacy, Maasland Hospital, Sittard, The Netherlands.

Insights

Amphotericin B is stable in Dianeal CAPD fluid, crucial for treating fungal peritonitis. Degradation in dextrose and effluent depends on concentration, with higher doses showing less breakdown.

Area of Science:

  • Pharmacology
  • Nephrology
  • Clinical Pharmacy

Background:

  • Amphotericin B is the preferred treatment for fungal peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
  • CAPD fluids contain anions (chloride, lactate) that may cause incompatibility with amphotericin B.
  • Understanding amphotericin B stability in CAPD solutions is vital for effective treatment.

Purpose of the Study:

  • To evaluate the physical and chemical compatibility of amphotericin B with common CAPD components.
  • To determine the stability of amphotericin B in dextrose 5%, Dianeal 1.36% CAPD fluid, and peritoneal effluent.

Main Methods:

  • Amphotericin B solutions at 1, 2, and 5 mg/L were prepared.
  • Compatibility was assessed in dextrose 5%, Dianeal 1.36% CAPD fluid, and peritoneal effluent.
  • Incubation at 37°C for 6 hours followed by analysis of decomposition.

Main Results:

  • Amphotericin B demonstrated highest stability in Dianeal 1.36% CAPD fluid across all tested concentrations.
  • Degradation rate in dextrose 5% and effluent was concentration-dependent, decreasing with higher amphotericin B concentrations.
  • No significant decomposition of amphotericin B was observed in Dianeal CAPD fluid after 6 hours, while 12-18% decomposition occurred in effluent.

Conclusions:

  • Dianeal 1.36% CAPD fluid provides a stable medium for amphotericin B administration.
  • Concentration influences amphotericin B degradation in dextrose and effluent, necessitating careful dosing.
  • No physical incompatibilities were noted, supporting its use in CAPD fungal peritonitis.

Related Concept Videos